Tipping point, over the top, or just noncompliance as usual?

Hastings Center Report 38 (2):27-29 (2008)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

2012

DOI

10.1353/hcr.2008.0023

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 93,590

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Index.[author unknown] - 2012 - Hastings Center Report 38 (6):48-51.
The Usual Suspects.Kenneth V. Iserson & Ferdinand Schoeman - 2012 - Hastings Center Report 22 (2):56-57.
The Usual Suspects.Kenneth V. Iserson & Ferdinand Schoeman - 1992 - Hastings Center Report 22 (2):56-57.
Top‐Down Savings.Leo Uzych - 1996 - Hastings Center Report 26 (5):3-3.
The Top Ten Reasons Not To Mary a Bioethicist.Lawrence J. Nelson & Ronald Cranford - 1995 - Hastings Center Report 25 (5):48-48.
FDA and the Life‐Sciences Industry: Business as Usual.Greg Koski - 2004 - Hastings Center Report 34 (5):24-27.
FDA and the life-sciences industry: business as usual?".B. W. Rein - 2005 - Hastings Center Report 35 (2):7.
Noncompliance in AIDS Research.John D. Arras - 1990 - Hastings Center Report 20 (5):24-32.
Just deserts?Peter J. Cohen - 2007 - Hastings Center Report 37 (3):5-6.
The Controversy over SUPPORT Continues and the Hyperbole Increases.Alan R. Fleischman - 2015 - Hastings Center Report 45 (1):42-44.

Analytics

Added to PP
2009-01-28

Downloads
46 (#106,786)

6 months
3 (#1,723,834)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references